GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (XTER:AAQ1) » Definitions » Cash And Cash Equivalents

aap Implantate AG (XTER:AAQ1) Cash And Cash Equivalents : €0.78 Mil (As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG Cash And Cash Equivalents?

aap Implantate AG's quarterly cash and cash equivalents declined from Jun. 2023 (€1.40 Mil) to Dec. 2023 (€1.28 Mil) but then stayed the same from Dec. 2023 (€1.28 Mil) to Jun. 2024 (€0.78 Mil).

aap Implantate AG's annual cash and cash equivalents declined from Dec. 2021 (€2.11 Mil) to Dec. 2022 (€0.24 Mil) but then increased from Dec. 2022 (€0.24 Mil) to Dec. 2023 (€1.28 Mil).


aap Implantate AG Cash And Cash Equivalents Historical Data

The historical data trend for aap Implantate AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG Cash And Cash Equivalents Chart

aap Implantate AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.93 0.89 2.11 0.24 1.28

aap Implantate AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.24 1.40 1.28 0.78

aap Implantate AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


aap Implantate AG  (XTER:AAQ1) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


aap Implantate AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


aap Implantate AG Business Description

Traded in Other Exchanges
Address
Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
Executives
Rubino Di Girolamo Board of Directors

aap Implantate AG Headlines

No Headlines